Atlas Trials

A Clinical Study on Levosimendan Improvement of Prognosis of ARDS Patients by Optimizing Pulmonary Hemodynamics

Clinical trial NCT04020003 · UNKNOWN

Trial details

NCT number
NCT04020003
Sponsor
Shenzhen Second People's Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
ARDS, Human
Start date
2019-07-01
Primary completion
2021-12-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.